Andrew "Drew" Senyei M.D. – Chairman

Dr. Senyei has more than 25 years of experience in the building of emerging, life science and healthcare companies. Dr. Senyei has served on the Boards of more than 30 private and public companies including: Genoptix (NASDAQ), Adeza (NASDAQ), Complete Genomics (NASDAQ) and Genetrix.

Dr. Senyei received his M.D. from Northwestern University and completed his residency training in Obstetrics and Gynecology at the University of California, Irvine, where he served on the faculty prior to becoming active full-time with early stage medical companies.

Haichuan Zhang, Ph.D. – CEO

Dr. Zhang received his Ph.D. from Tsinghua University (Beijing).

He was founder, President and COO of Celula, where he led multi-disciplinary development team for novel solutions in non-invasive prenatal testing, liquid biopsy for cancer and single cell analysis instrumentation. Dr. Zhang has been General Manager of Celula China since its establishment. Dr. Zhang was in Genoptix Inc. and Call/Recall Inc. before Celula. Dr. Zhang is inventor of more than 50 patents and patent applications.